Untargeted metabolomic profiling of serum and urine in kidney cancer: a non-invasive approach for biomarker discovery - The Ossolińscy Family

Untargeted metabolomic profiling of serum and urine in kidney cancer: a non-invasive approach for biomarker discovery

Publication date: July 2025

Serum and urine analysis with gold nanoparticle‑assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery

Publication date: July 2021

Metabolomic and elemental profiling of human tissue in kidney cancer

Publication date: March 2021

Screening of Urinary Renal Cancer Metabolic Biomarkers with Gold Nanoparticles‑assisted Laser Desorption/Ionization Mass Spectrometry

Publication date: August 2020

Review on the Significance of GDNF, PTCH1, and RNF213 in Chromophobe Renal Cell Carcinoma Illustrated by the Case of a 71-Year-Old Man

Publication date: October 2020

Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer

Publication date: July 2020

Gold nanostructures- assisted laser desorption/ionization mass spectrometry for kidney cancer blood serum biomarker screening

Publication date: October 2020